Abstract
It was proposed that increased level of mitochondrial reactive oxygen species (ROS), mediating execution of the aging program of an organism, could also be critical for neoplastic transformation and tumorigenesis. This proposal was addressed using new mitochondria-targeted antioxidant SkQ1 (10-(6′-plastoquinonyl) decyltriphenylphosphonium) that scavenges ROS in mitochondria at nanomolar concentrations. We found that diet supplementation with SkQ1 (5 nmol/kg per day) suppressed spontaneous development of tumors (predominantly lymphomas) in p53-/- mice. The same dose of SkQ1 inhibited the growth of human colon carcinoma HCT116/p53-/- xenografts in athymic mice. Growth of tumor xenografts of human HPV-16-associated cervical carcinoma SiHa was affected by SkQ1 only slightly, but survival of tumor-bearing animals was increased. It was also shown that SkQ1 inhibited the tumor cell proliferation, which was demonstrated for HCT116 p53-/- and SiHa cells in culture. Moreover, SkQ1 induced differentiation of various tumor cells in vitro. Coordinated SkQ1-initiated changes in cell shape, cytoskeleton organization, and E-cadherin-positive intercellular contacts were observed in epithelial tumor cells. In Ras- and SV40-transformed fibroblasts, SkQ1 was found to initiate reversal of morphological transformation of a malignant type, restoring actin stress fibers and focal adhesion contacts. SkQ1 suppressed angiogenesis in Matrigel implants, indicating that mitochondrial ROS could be important for tumor angiogenesis. This effect, however, was less pronounced in HCT116/p53-/- tumor xenografts. We have also shown that SkQ1 and related positively charged antioxidants are substrates of the P-glycoprotein multidrug resistance pump. The lower anti-tumor effect and decreased intracellular accumulation of SkQ1, found in the case of HCT116 xenografts bearing mutant forms of p53, could be related to a higher level of P-glycoprotein. The effects of traditional antioxidant N-acetyl-L-cysteine (NAC) on tumor growth and tumor cell phenotype were similar to the effects of SkQ1 but more than 1,000,000 times higher doses of NAC than those of SkQ1 were required. Extremely high efficiency of SkQ1, related to its accumulation in the mitochondrial membrane, indicates that mitochondrial ROS production is critical for tumorigenesis at least in some animal models.
Similar content being viewed by others
Abbreviations
- DCF:
-
2′,7′-dichlorodihydrofluorescein diacetate
- FBS:
-
fetal bovine serum
- MDR:
-
multiple drug resistance
- NAC:
-
N-acetyl-L-cysteine
- PBS:
-
phosphate-buffered saline
- ROS:
-
reactive oxygen species
- SkQ1:
-
10-(6′-plastoquinonyl) decyltriphen-ylphosphonium
- SkQR1:
-
10-(6′-plastoquinonyl) decylrhodamine 19
References
Skulachev, V. P. (2007) Biochemistry (Moscow), 72, 1385–1396.
Hussain, S. P., Hofseth, L. J., and Harris, C. C. (2003) Nat. Rev. Cancer, 3, 276–285.
Wallace, D. C. (2005) Cold Spring Harbor Symp. Quant. Biol., 70, 363–374.
Wu, W. S. (2006) Cancer Metastasis Rev., 25, 695–705.
Blanchetot, C., and Boonstra, J. (2008) Crit. Rev. Eukaryot. Gene Expr., 18, 35–45.
Kopnin, B. P. (2007) Mol. Biol. (Moscow), 41, 369–380.
Giles, G. I. (2006) Curr. Pharm. Des., 12, 4427–4443.
Nagai, H., Noguchi, T., Takeda, K., and Ichijo, H. (2007) J. Biochem. Mol. Biol., 40, 1–6.
Alexandrova, A. Y., Kopnin, P. B., Vasiliev, J. M., and Kopnin, B. P. (2006) Exp. Cell Res., 312, 2066–2073.
Sablina, A. A., Budanov, A. V., Ilyinskaya, G. V., Agapova, L. S., Kravchenko, J. E., and Chumakov, P. M. (2005) Nat. Med., 11, 1306–1313.
Kopnin, P. B., Agapova, L. S., Kopnin, B. P., and Chumakov, P. M. (2007) Cancer Res., 67, 4571–4578.
Vafa, O., Wade, M., Kern, S., Beeche, M., Pandita, T. K., Hampton, G. M., and Wahl, G. M. (2002) Mol. Cell., 9, 1031–1044.
Irani, K., Xia, Y., Zweier, J. L., Sollott, S. J., Der, C. J., Fearon, E. R., Sundaresan, M., Finkel, T., and Goldschmidt-Clermont, P. J. (1997) Science, 275, 1649–1652.
Gerald, D., Berra, E., Frapart, Y. M., Chan, D. A., Giaccia, A. J., Mansuy, D., Pouyssegur, J., Yaniv, M., and Mechta-Grigoriou, F. (2004) Cell, 118, 781–794.
Khromova, N. V., Kopnin, P. B., Stepanova, E. V., Agapova, L. S., and Kopnin, B. P. (2008) Cancer Lett., submitted (Ms#CAN-S-08-00360).
Xia, C., Meng, Q., Liu, L. Z., Rojanasakul, Y., Wang, X. R., and Jiang, B. H. (2007) Cancer Res., 67, 10823–10830.
Kopnin, B. P., Khromova, N. V., Kopnin, P. B., and Agapova, L. S. (2008) Clin. Oncohemat., 1, 3–11.
Carcamo, J. M., and Golde, D. W. (2006) Mutat. Res., 593, 64–79.
Skulachev, V. P. (1996) FEBS Lett., 397, 7–10.
Skulachev, V. P. (1996) Quart. Rev. Biophys., 29, 169–202.
Skulachev, V. P. (2003) in Topics in Current Genetics, Vol. 3 (Nystrom, T., and Osiewac, H. D., eds.) Springer-Verlag, Berlin-Heidelberg, pp. 191–238.
Zhang, D. X., and Gutterman, D. D. (2007) Am. J. Physiol. Heart Circ. Physiol., 292, H2023–2031.
Scherz-Shouval, R., and Elazar, Z. (2007) Trends Cell Biol., 17, 422–427.
Antonenko, Y. N., Avetisyan, A. V., Bakeeva, L. E., Chernyak, B. V., Chertkov, V. A., Domnina, L. V., Ivanova, O. Yu., Izyumov, D. S., Khailova, L. S., Klishin, S. S., Korshunova, G. A., Lyamzaev, K. G., Muntyan, M. S., Nepryakhina, O. K., Pashkovskaya, A. A., Pletjushkina, O. Yu., Pustovidko, A. V., Roginsky, V. A., Rokitskaya, T. I., Ruuge, E. K., Saprunova, V. B., Severina, I. I., Simonyan, R. A., Skulachev, I. V., Skulachev, M. V., Sumbatyan, N. V., Sviryaeva, I. V., Tashlitsky, V. N., Vassiliev, J. M., Vyssokikh, M. Yu., Yaguzhinsky, L. S., Zamyatnin, A. A., Jr., and Skulachev, V. P. (2008) Biochemistry (Moscow), 73, 1273–1287.
Bakeeva, L. E., Barskov, I. V., Egorov, M. V., Isaev, N. K., Kapelko, V. I., Kazachenko, A. V., Kirpatovsky, V. I., Kozlovsky, S. V., Lakomkin, V. L., Levina, S. V., Pisarenko, O. I., Plotnikov, E. Y., Saprunova, V. B., Serebryakova, L. I., Skulachev, M. V., Stelmashook, E. V., Studneva, I. M., Tskitishvili, O. V., Vasileva, A. K., Victorov, I. V., Zorov, D. B., and Skulachev, V. P. (2008) Biochemistry (Moscow), 73, 1288–1299.
Neroev, V. V., Archipova, M. M., Bakeeva, L. E., Fursova, A. Zh., Grigorian, E. N., Grishanova, A. Yu., Iomdina, E. N., Ivashchenko, Zh. N., Katargina, L. A., Khoroshilova-Maslova, I. P., Kilina, O. V., Kolosova, N. G., Kopenkin, E. P., Korshunov, S. S., Kovaleva, N. A., Novikova, Yu. P., Philippov, P. P., Pilipenko, D. I., Robustova, O. V., Saprunova, V. B., Senin, I. I., Skulachev, M. V., Sotnikova, L. F., Stefanova, N. A., Tikhomirova, N. K., Tsapenko, I. V., Schipanova, A. I., Zinovkin, R. A., and Skulachev, V. P. (2008) Biochemistry (Moscow), 73, 1317–1328.
Anisimov, V. N., Bakeeva, L. E., Egormin, P. A., Filenko, O. F., Isakova, E. F., Manskikh, V. N., Mikhelson, V. M., Panteleeva, A. A., Pasyukova, E. G., Pilipenko, D. I., Piskunova, T. S., Popovich, I. G., Roshchina, N. V., Rybina, O. Yu., Samoylova, T. A., Saprunova, V. B., Semenchenko, A. V., Skulachev, M. V., Spivak, I. M., Tsybul’ko, E. A., Tyndyk, M. L., Vyssokikh, M. Yu., Yurova, M. N., Zabezhinsky, M. A., and Skulachev, V. P. (2008) Biochemistry (Moscow), 73, 1329–1342.
Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Jr., Butel, J. S., and Bradley, A. (1992) Nature, 356, 215–221.
Jacks, T., Remington, L., Williams, B. O., Schmitt, E. M., Halachmi, S., Bronson, R. T., and Weinberg, R. A. (1994) Curr. Biol., 4, 1–7.
Soussi, T. (2005) in 25 Years of p53 Research (Hainaut, P., and Wiman, K. G., eds.) Springer, Dordrecht-Berlin-Heidelberg-New York, pp. 255–292.
Shi, H., Calvez, F. L., Olivier, M., and Hainaut, P. (2005) in 25 Years of p53 Research (Hainaut, P., and Wiman, K. G., eds.) Springer, Dordrecht-Berlin-Heidelberg-New York, pp. 293–320.
Chumakov, P. M. (2007) Biochemistry (Moscow), 72, 1399–1421.
Bunz, F., Dutriaux, A., Lengauer, C., Waldman, T., Zhou, S., Brown, J. P., Sedivy, J. M., Kinzler, K. W., and Vogelstein, B. (1998) Science, 282, 1497–1500.
Kalinina, E. V., Chernov, N. N., Saprin, A. N., Kotova, Y. N., Andreev, Y. A., Solomka, V. S., and Scherbak, N. P. (2006) Biochemistry (Moscow), 71, 1200–1206.
Kopnin, B. P., Stromskaya, T. P., Kondratov, R. V., Ossovskaya, V. S., Pugacheva, E. N., Rybalkina, E. Y., Khokhlova, O. A., and Chumakov, P. M. (1995) Oncol. Res., 7, 299–306.
Huschtscha, L. I., and Holliday, R. (1983) J. Cell Sci., 63, 77–99.
Kopnin, P. B., Kravchenko, I. V., Furalyov, V. A., Pylev, L. N., and Kopnin, B. P. (2004) Oncogene, 23, 8834–8840.
Sablina, A. A., Chumakov, P. M., and Kopnin, B. P. (2003) J. Biol. Chem., 278, 27362–27371.
Logunov, D. Y., Ilyinskaya, G. V., Cherenova, L. V., Verhovskaya, L. V., Shmarov, M. M., Chumakov, P. M., Kopnin, B. P., and Naroditsky, B. S. (2004) Gene Ther., 11, 79–84.
Hirota, K., and Semenza, G. L. (2006) Crit. Rev. Oncol. Hematol., 59, 15–26.
Bell, E. L., Klimova, T. A., Eisenbart, J., Moraes, C. T., Murphy, M. P., Budinger, G. R., and Chande, N. S. (2007) J. Cell Biol., 177, 1029–1036.
Sherr, C. J., and Roberts, J. M. (1999) Genes Dev., 13, 1501–1512.
Mainprize, T. G., Taylor, M. D., Rutka, J. T., and Dirks, P. B. (2001) J. Neurooncol., 51, 205–218.
Levine, A. J., Hu, W., and Feng, Z. (2006) Cell Death Differ., 13, 1027–1036.
Harms, K., Nozell, S., and Chen, X. (2004) Cell Mol. Life Sci., 61, 822–842.
Pugacheva, E. N., Roegiers, F., and Golemis, E. A. (2006) Curr. Opin. Cell Biol., 18, 507–515.
Brembeck, F. H., Rosario, M., and Birchmeier, W. (2006) Curr. Opin. Genet. Dev., 16, 51–59.
Zhang, J., Betson, M., Erasmus, J., Zeikos, K., Bailly, M., Cramer, L. P., and Braga, V. M. M. (2005) J. Cell Sci., 118, 5549–5562.
Lozano, E., Betson, M., and Braga, V. M. M. (2003) BioEssays, 25, 452–463.
Parasassi, T., Brunelli, R., Bracci-Laudiero, L., Greco, G., Gustafsson, A. C., Krasnowska, E. K., Lundeberg, J., Lundeberg, T., Pittaluga, E., Romano, M. C., and Serafino, A. (2005) Cell Death Differ., 12, 1285–1296.
Campbell, P. M., and Der, C. J. (2004) Semin. Cancer Biol., 14, 105–114.
Lee, S., and Helfman, D. M. (2004) J. Biol. Chem., 279, 1885–1891.
DesMarais, V., Ghosh, M., Eddy, R., and Condeelis, J. (2005) J. Cell Sci., 118, 19–26.
Stavrovskaya, A. A. (2000) Biochemistry (Moscow), 65, 95–106.
Glavinas, H., Krajcsi, P., Cserepes, J., and Sarkadi, B. (2004) Curr. Drug Deliv., 1, 27–42.
Thottassery, J. V., Zambetti, G. P., Arimori, K., Schuetz, E. G., and Schuetz, J. D. (1997) Proc. Natl. Acad. Sci. USA, 94, 11037–11042.
Sampath, J., Sun, D., Kidd, V. J., Grenet, J., Gandhi, A., Shapiro, L. H., Wang, Q., Zambetti, G. P., and Schuetz, J. D. (2001) J. Biol. Chem., 276, 39359–29367.
Kabanov, A. V., Batrakova, E. V., and Alakhov, V. Y. (2002) Adv. Drug Deliv. Rev., 54, 759–779.
Skulachev, V. P. (1999) Biochemistry (Moscow), 64, 1418–1426.
Qanungo, S., Wang, M., and Nieminen, A. L. (2004) J. Biol. Chem., 279, 50455–50464.
Qanungo, S., Starke, D. W., Pai, H. V., Mieyal, J. J., and Nieminen, A. L. (2007) J. Biol. Chem., 282, 18427–18436.
Author information
Authors and Affiliations
Corresponding author
Additional information
Published in Russian in Biokhimiya, 2008, Vol. 73, No. 12, pp. 1622–1640.
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Agapova, L.S., Chernyak, B.V., Domnina, L.V. et al. Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 3. Inhibitory effect of SkQ1 on tumor development from p53-deficient cells. Biochemistry Moscow 73, 1300–1316 (2008). https://doi.org/10.1134/S0006297908120031
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S0006297908120031